Nina Capital funding news – Barcelona-based VC firm Nina Capital Announced First Close of Fund III at €50 Million

The fund is supported by investors like the Boston-based wealth management firm Seven Two Partners, along with family offices, foundations, corporations, and individuals from Europe and the U.S.

Dr Marta G. Zanchi, Founder and Managing Director at Nina Capital said, “Healthcare is at an inflection point. We see extraordinary opportunities for innovation to break down inefficiencies, increase access, and improve outcomes. Fund III solidifies our commitment to finding and supporting the boldest minds tackling healthcare’s most urgent challenges, Our mission is clear: to find and support the founders who are solving timely and compelling healthcare needs, blending technology innovation with sound business models built on a solid understanding of healthcare market incentives and constraints.”

Building on the success of its earlier funds, Nina Capital has already made its first investment in Fund III: Sonar Mental Health, a U.S.-based platform that helps students in school districts nationwide with a mix of AI and human support.

There are two more investments planned for early 2025. Fund III focuses on healthcare technologies that make a real, measurable impact.

Read also - Pixel Photonics funding news – Munster-based DeepTech Startup Pixel Photonics Secures €1 Million in Funding

Nina Capital also shared that startups from Fund I had an 80% success rate in moving to the next stage, and companies from Fund II grew their revenue almost five times within two years of investment.

Subirats said, "Dr Marta G. Zanchi, a former director of Stanford Biodesign’s Digital Health initiatives and medical technology executive, and Marc Subirats, an accomplished entrepreneur whose telemedicine company Advance Medical was acquired by Teladoc Health, bring relevant hands-on experience to their roles as General Partners. This fund is the next natural chapter of our story, building on a proven strategy and team,".

Andrew Macken, Managing Partner at Seven Two said, “Healthcare is at the forefront of a transformative era, where groundbreaking innovations are creating immense opportunities for both patient impact and investors, For the best outcomes in this complex industry, we believe that it is important for managers to find great founders who are working on solving these significant problems and for those managers to help these businesses grow. We are impressed with the work that Marta and her team have accomplished and excited to see what Nina Capital has in store to reshape the future of healthcare.”

Like its previous funds, Fund III will focus on three key areas in health technology:

Clinical Innovation and Education – Supporting new solutions in diagnostics, medical devices, and training for healthcare professionals.

Healthcare Infrastructure – Improving data-driven processes in research, clinical trials, pharmaceutical logistics, and manufacturing.

Clinical Pathways and Health Data – Enhancing care delivery with technology and improving operational efficiency.

About Nina Capital

Founded in 2019 by Dr. Marta G. Zanchi, Nina Capital aims to build a new investment portfolio in Europe, North America, Israel, and, for the first time, Australia with Fund III. Their vision is to use data, technology, and innovation to improve healthcare and outcomes for patients.